Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice.

Van Belle S, Swieboda-Sadlej A, Karanikiotis C, Labourey JL, Galid A, Wheeler T, Pujol B, Aerts JG.

Curr Med Res Opin. 2012 Jul;28(7):1079-87. doi: 10.1185/03007995.2012.698601. Epub 2012 Jun 21.

PMID:
22642867
[PubMed - indexed for MEDLINE]
2.

Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.

Aerts JG, Swieboda-Sadlej A, Karanikiotis C, Labourey JL, Galid A, Wheeler T, Pujol B, Van Belle S.

Curr Med Res Opin. 2012 Jul;28(7):1089-99. doi: 10.1185/03007995.2012.698602. Epub 2012 Jun 21.

PMID:
22642866
[PubMed - indexed for MEDLINE]
3.

Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy - data from the CHOICE study.

Van Belle S, Karanikiotis C, Labourey JL, Galid A, Wheeler T, Pujol B.

Curr Med Res Opin. 2011 May;27(5):987-94. doi: 10.1185/03007995.2011.562493. Epub 2011 Mar 9.

PMID:
21385113
[PubMed - indexed for MEDLINE]
4.

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.

Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2009 Sep 15;15(18):5888-94. doi: 10.1158/1078-0432.CCR-09-0728. Epub 2009 Sep 1.

PMID:
19723645
[PubMed - indexed for MEDLINE]
Free Article
5.

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R; ABCSG-12 Trial Investigators, Marth C.

N Engl J Med. 2009 Feb 12;360(7):679-91. doi: 10.1056/NEJMoa0806285. Erratum in: N Engl J Med. 2009 May 28;360(22):2379.

PMID:
19213681
[PubMed - indexed for MEDLINE]
Free Article
6.

Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.

Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2008 Apr 1;14(7):2082-7. doi: 10.1158/1078-0432.CCR-07-2068.

PMID:
18381948
[PubMed - indexed for MEDLINE]
Free Article
7.

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.

Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2008 Mar 15;14(6):1767-74. doi: 10.1158/1078-0432.CCR-07-4122.

PMID:
18347178
[PubMed - indexed for MEDLINE]
Free Article
8.

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).

Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R; Austrian Breast, Colorectal Cancer Study Group (ABCSG).

Breast Cancer Res Treat. 2008 Nov;112(1):203-13. Epub 2007 Dec 22.

PMID:
18158620
[PubMed - indexed for MEDLINE]
9.

Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R; ABCSG-14.

J Clin Oncol. 2007 May 20;25(15):2012-8.

PMID:
17513805
[PubMed - indexed for MEDLINE]
Free Article
10.

Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.

Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, Grampp S, Kaessmann H, Schmid M, Menzel C, Piswanger-Soelkner JC, Galid A, Mittlboeck M, Hausmaninger H, Jakesz R; Austrian Breast and Colorectal Cancer Study Group.

J Clin Oncol. 2007 Mar 1;25(7):820-8. Epub 2006 Dec 11.

PMID:
17159195
[PubMed - indexed for MEDLINE]
Free Article
11.

Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.

Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH.

Radiology. 2006 Nov;241(2):367-77.

PMID:
17057065
[PubMed - indexed for MEDLINE]
12.

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.

Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB.

Gynecol Oncol. 2004 Jun;93(3):686-90.

PMID:
15196865
[PubMed - indexed for MEDLINE]
13.

Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment.

Singer CF, Hudelist G, Galid A, Kubista E.

Drugs Today (Barc). 2003 Dec;39(12):917-26. Review.

PMID:
14747837
[PubMed - indexed for MEDLINE]
14.

Impact of pretreatment thrombocytosis on survival in primary breast cancer.

Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R; Austrian Breast and Colorectal Cancer Study Group.

Thromb Haemost. 2003 Jun;89(6):1098-106.

PMID:
12783124
[PubMed - indexed for MEDLINE]
15.

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.

Green MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ; International Pegfilgrastim 749 Study Group.

Ann Oncol. 2003 Jan;14(1):29-35.

PMID:
12488289
[PubMed - indexed for MEDLINE]
Free Article
16.

The oestrogen receptor and its selective modulators in gynaecological oncology.

Seifert M, Galid A, Kubista E.

Eur J Cancer. 2000 Sep;36 Suppl 4:S66-7. No abstract available.

PMID:
11056325
[PubMed - indexed for MEDLINE]
17.

Estrogen replacement therapy in women with a history of breast cancer.

Seifert M, Galid A, Kubista E.

Maturitas. 1999 Jun 21;32(2):63-8. Review.

PMID:
10465373
[PubMed - indexed for MEDLINE]
18.

[Oral contraceptives and breast cancer--a causal relationship?].

Seifert M, Galid A.

Gynakol Geburtshilfliche Rundsch. 1998;38(2):101-4. German.

PMID:
9815527
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk